ExeGi Pharma

Visbiome Unflavored High Potency Probiotic
Visbiome Unflavored High Potency Probiotic
Visbiome Unflavored High Potency Probiotic
Visbiome Unflavored High Potency Probiotic

Visbiome Unflavored High Potency Probiotic


By ExeGi Pharma
MSRP: $92.95
$85.00

Add to Bag

Product Description:

Unflavored Visbiome Powder. 450 billion CFUs per packet. 30 packets per box.

Originally labelled VSL#3, Visbiome is a high potency probiotic medical food intended for the dietary management of dysbiosis associated with irritable bowel syndrome (IBS), ulcerative colitis (UC), pouchitis, and hepatic encephalopathy (HE).

Visbiome Unflavored is a medical food to be used under physician supervision. Regular strength Visbiome does not require a prescription.

Inactive ingredients: corn starch.

Visbiome contains milk. Visbiome may contain trace amounts of lactose (less than 0.1g per 100g) and dehydrated skim milk or milk protein (casein and beta-lacto globulin of less than 2mg/kg).

Visbiome is made in the U.S.A

Product Specifications:

VISBIOME contains the De Simone Formulation, a proprietary blend of live, lyophilized, probiotic bacteria

  • Lactobacillus acidophilus DSM24735TM
  • Lactobacillus plantarum DSM24730TM
  • Lactobacillus paracasei DSM24733TM
  • Lactobacillus delbrueckii subsp. bulgaricus† DSM24734TM
  • Streptococcus thermophilus DSM24731TM
  • Bifidobacterium longum± DSM24736TM
  • Bifidobacterium breve DSM24732TM
  • Bifidobacterium infantis± DSM24737TM
±Recently reclassified as Bifidobacterium lactis
†Recently reclassified as Lactobacillus helveticus

The designation numbers for the strains in Visbiome are trademarks of ExeGi Pharma, LLC.

Adverse Reactions
Mild abdominal bloating has been reported occasionally during the first few days of consuming VISBIOME. This is generally a readjustment of the microflora, which usually diminishes within 3 - 4 days. If bloating persists, the patient should reduce their intake for a few days and consult with their healthcare provider.

Drug Interactions
There are no known adverse drug interactions associated with consumption of VISBIOME. Some strains of bacteria in VISBIOME may be inactivated by certain antibiotics. Do not consume VISBIOME within four (4) hours after taking antibiotics.

Use in Specific Populations
The probiotic formulation in VISBIOME has been the subject of studies in adults and children between the ages of 3 months to 17 years. If you are pregnant or nursing, please consult with your healthcare provider before consuming Visbiome

Safety and Overdosage
Probiotics have a long history of safe use, having been consumed for health benefit and as part of fermented foods for millennia. Many bifidobacteria and lactobacilli species are normal, nonpathogenic inhabitants of the human gastrointestinal tract, oral cavity, skin, and vagina. Documented cases of infection attributable to probiotic intake are limited to individual case reports, primarily associated with the use of probiotics in severely immunocompromised patients. VISBIOME has been the subject of clinical trials in ART treated HIV-1 positive patients.

The probiotic bacteria in VISBIOME are non-pathogenic, non-toxigenic and Generally Recognized as Safe (GRAS) as food ingredients.

The De Simone Formulation in VISBIOME has been the subject of over 70 clinical studies involving over 5,000 adult and pediatric patients (ages 3 months - 17 years), including immunocompromised individuals. The most common reported adverse events were abdominal bloating and/or gas, generally reported within the first few days of probiotic consumption.

VISBIOME has been administered in clinical evaluation in daily dosages of up to 3,600 billion (3,600 x 109) CFUs per day for 12 weeks.